Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 4, July, p. 601–608

doi: 10.17219/acem/62663

PubMed ID: 28691426

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Physical activity – related changes in ADMA and vWF levels in patients with type 2 diabetes: A preliminary study

Zanna Fiodorenko-Dumas1,D, Ilias Dumas1,A, Krzysztof Mastej2,B, Rajmund Adamiec2,E,F

1 Department of Physiotherapy, Wroclaw Medical University, Poland

2 Department of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Poland

Abstract

Background. The activity and the role of methylarginine in diabetic patients are subject to continuous research. The mechanism through which diabetes or insulin resistance increases asymmetric dimethylarginine (ADMA) serum levels is not fully understood. Studies indicate increased ADMA serum levels in patients with hypertension, hypercholesterolemia and hyperhomocysteinemia.
Objectives. The aim of the study was to assess the changes in ADMA levels and its derivatives related to the current disease process, as well as the levels of selected prothrombotic factors and their changes induced by physical activity.
Material and Methods. The study included 44 patients: group A (22 patients) – patients with diabetes with no vascular complications with mean age of 55.83 ± 7.37 years; and group B (22 patients) – healthy volunteers with the mean age of 51.16 ± 6.39 years. The authors’ questionnaire was used to collect sociodemographic data in the study group. Physical exercise (Nordic walking) was practiced once per day for 30 min, 5 times a week. The assessment of peripheral blood parameters was performed using the ABX MICROS OT 16-parameter hematology analyzer. Additionally, chromatographic assay of serum levels of L-arginine, ADMA and symmetric dimethylarginine (SDMA) was performed.
Results. There were statistically significant differences in ADMA levels in the respondents with type 2 diabetes vs healthy volunteers after training (0.763 ± 0.043 vs 0.532 ± 0.046; p = 0.001).
Conclusion. ADMA and SDMA levels in diabetic patients significantly exceeded standard values.

Key words

diabetes, atherosclerosis, physical exercise, ADMA

References (31)

  1. Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572.
  2. Surdacki A, Nowicki M, Sadmann J, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol. 1999;33:652.
  3. Böger RH, Bode-Böger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation. 1998;98:1842.
  4. Sydow K, Schwedhelm E, Arakawa N, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: Effects of L-arginine and B vitamins. Cardiovasc Res. 2003;57:244.
  5. Abbasi F, Asagni T, Cooke JP, et al. Plasma concentration of asymmetric dimethylarginine are increased in patient with type 2 diabetes mellitus. Am J Cardiol. 2001;88:1201.
  6. Lin KY, Ito A, Asagami T, et al. Impaired nitric oxide synthase pathway in diabetes mellitus. Role of asymmetric dimethylarginine and dimethyl-arginine dimethylaminohydrolase. Circulation. 2002;106:987.
  7. Stuhlinger MC, Abbasi F, Chu JW, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287:1420.
  8. Fard A, Tuck CH, Donis JA, et al. Acute elevation of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20:2039.
  9. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol. 2004;24:1023.
  10. Chełmińska K. Wpływ wysiłku fizycznego na występowanie i przebieg cukrzycy. Przegl Lek. 1997;54:62–66.
  11. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20:2032.
  12. MacAllister RJ, Rambausek MH, Vallance P, et al. Concentration of dimethyl-L-arginine in the plasma of patient with end-stage renal failure. Nephrol Dial Transplant. 1996;11:2449.
  13. Nadar S, Blann AD, Lip GYH. Endothelial dysfunction. Methods of assessment and application to hypertension. Curr Pharm Des. 2004;10:3591–3605.
  14. Czech A, Tatoń J, Bernas M, Łaz R, Szczeklik-Kumala Z. Tolerancja wysiłków fizycznych jako czynnik determinujący stosowanie leczenia treningiem fizycznym u osób z cukrzycą. Przew Lek. 2001;4(5):37–43.
  15. Kraśnicki P, Proniewska-Skrętek E, Dmuchowska DA, Dobrzycki S, Mariak Z. Asymetryczna dimetyloarginina (ADMA) jako marker zaburzeń przepływu krwi przez naczynia zaopatrujące gałkę oczną u pacjentów z cukrzycą typu 2 i chorobą niedokrwienną serca. Magazyn Lekarza Okulisty. 2009;3(6):325–330.
  16. Cooke JP. Asymmetrical dimethylarginine. The über marker? Circulation. 2004;109:1813.
  17. Horl WH. Uremic toxins: New aspects. J Nephrol. 2000;13(Suppl. 3):S83.
  18. Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylamino-hydrolase. Arterioscler Tromb Vasc Biol. 2003;23:1455.
  19. Chan JR, Böger RH, Bode-Böger SM, et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol. 2000;20:1040.
  20. Neubauer-Geryk J, Bieniaszewski L. Metody oceny funkcji śródbłonka. Wazodylatacja tętnicy ramiennej po niedokrwieniu, Choroby Serca i Naczyń. 2007;4(4):190–196.
  21. Kotschy M, Polaszewska-Muszyńska M, Będowska-Gontarz W, Sikorska Z, Moskal S. Von Willebrand factor and tissue plasminogen activator as vascular endothelial markers in diabetes type 2. Acta Angiol. 2003;9(2):63–69.
  22. Fujiwara Y, Tagami S, Kawakami Y. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy. J Atheroscler Thromb. 1998;5:21–28.
  23. Otto Buczkowska E, Jarosz-Chobot P. Znaczenie leczniczego treningu fizycznego w leczeniu cukrzycy. Ped Endocrinol Diab Metab. 1999;5(1):35–38.
  24. Wierusz-Wysocka B, Zozulińska D. Wybrane mechanizmy przewlekłych powikłań cukrzycy. Diabetol Pol. 2000;7:193–197.
  25. Morise T, Takeuchi Y, Kawano M, Koni I. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care. 1995;18(1):87–89.
  26. Pirsco D, Francalanci I, Filippini M, Hagi MI. Physical exercise and hemostasis. Int J Clin Lab Res. 1994;24(3):125–131.
  27. Schlager O, Giurgea A, Schuhfried O, et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial. Atherosclerosis. 2011;217(1):240–248.
  28. Teplan V, Mahrova A, Piťha J, et al. Early exercise training after renal transplantation and asymmetric dimethylarginine: The effect of obesity. Kidney & Blood Pressure Research. 2014;39(4):289–298.
  29. Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger G, Francesconi M, Wolzt M. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr. 2005;117(23–24):816–820.
  30. Peirce NS. Diabetes and exercise. Br J Sports Med. 1999;33(3):161–172.
  31. Lippi G, Maffulli N. Biological influence of physical exercise on hemostasis. Tromb Hemost. 2009;35(3):269–276.
© Wroclaw Medical University